Norges Bank Pulmonx Corp Transaction History

Norges Bank

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$5.77 - $9.82 $872,423 - $1.48 Million	151,200 New	151,200 $958,000
Q4 2023 Feb 09, 2024	BUY	$7.89 - $13.14 $2.97 Million - $4.95 Million	376,900 New	376,900 $4.81 Million
Q3 2023 Nov 13, 2024	BUY	$9.88 - $14.0 $3.72 Million - $5.28 Million	376,900 New	376,900 $3.89 Million
Q3 2023 Nov 13, 2023	SELL	$9.88 - $14.0 $2.23 Million - $3.17 Million	-226,100 Closed	0 $0
Q2 2023 Aug 14, 2024	BUY	$10.78 - $13.65 $2.44 Million - $3.09 Million	226,100 Added 149.54%	377,300 $4.95 Million
Q2 2023 Aug 14, 2023	SELL	$10.78 - $13.65 $2.51 Million - $3.18 Million	-233,100 Closed	0 $0
Q1 2023 May 15, 2024	BUY	$7.49 - $12.54 $1.69 Million - $2.84 Million	226,100 New	226,100 $2.53 Million
Q4 2022 Feb 14, 2023	BUY	$4.92 - $17.35 $1.84 Million - $6.49 Million	374,100 New	374,100 $3.15 Million
Q3 2022 Nov 13, 2023	BUY	$15.35 - $23.99 $3.47 Million - $5.42 Million	226,100 New	226,100 $3.77 Million
Q2 2022 Aug 14, 2023	BUY	$14.0 - $27.95 $3.26 Million - $6.52 Million	233,100 New	233,100 $3.43 Million
Q1 2022 May 09, 2022	SELL	$21.13 - $35.65 $863,794 - $1.46 Million	-40,880 Closed	0 $0
Q4 2021 Mar 09, 2022	BUY	$29.72 - $45.1 $1.21 Million - $1.84 Million	40,880 New	40,880 $1.31 Million
Q3 2021 Nov 14, 2022	BUY	$35.98 - $44.48 $1.47 Million - $1.82 Million	40,880 New	40,880 $1.47 Million
Q3 2021 Nov 05, 2021	SELL	$35.98 - $44.48 $1.04 Million - $1.28 Million	-28,800 Closed	0 $0
Q2 2021 Aug 15, 2022	BUY	$37.61 - $48.0 $1.08 Million - $1.38 Million	28,800 New	28,800 $1.27 Million

123

31M

300

204K

Ticker LUNG
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,268,400
Market Cap $236M
Description
Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

Stay updated on Norges Bank with notifications on news.